Ads
related to: asthma action plan 6 years later- Register For A Webinar
Learn From Medical Professionals
Hear From Real Patients Like You
- Getting Started
Learn More About Dosing Schedules
Find Answers To Your Questions
- Register For A Webinar
Search results
Results From The WOW.Com Content Network
More research is necessary to determine if shared decision-making is helpful for managing adults with asthma [174] or if a personalized asthma action plan is effective and necessary. [175] Some people with asthma use pulse oximeters to monitor their own blood oxygen levels during an asthma attack. However, there is no evidence regarding the use ...
The Allergy & Asthma Network unites and advocates on behalf of the 60 million Americans with allergies, asthma, and related conditions. The Network is tax-exempt, falling under section 501(3)(c) of the United States Internal Revenue Code. The organization was founded in 1985, by Nancy Sander, [1] the mother of a
The EPA estimated the Clean Power Plan would have reduced the pollutants that contribute to smog and soot by 25 percent, leading to 140,000 to 150,000 fewer asthma attacks among children and 2,700 to 6,600 fewer premature deaths. Net climate and health benefits were estimated between $25 billion and $45 billion per year beginning in 2030. [22]
GINA conducts continuous review of scientific publications on asthma and is a leader in disseminating information about the care of patients with asthma. [2] GINA publishes resources such as evidence-based guidelines for asthma management, and runs special events such as World Asthma Day. GINA's guidelines, revised each year, are used by ...
An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...
Asthma + Lung UK (formally Asthma and Lung UK) is a British charity based in London, England. It focuses on respiratory health, in particular asthma and lung disease. [2] [3] The organisation was formed in January 2020 as Asthma UK and the British Lung Foundation Partnership as a result of a merger between Asthma UK and the British Lung Foundation.
EXHALE-3: [6] a global Phase III clinical trial to evaluate the efficacy and safety of dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma, is currently recruiting people ≥12 years old with a documented physician diagnosis of asthma who require medium to high dose inhaled corticosteroids ...
Mepolizumab is approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of severe asthma in patients aged six years [6] or older and with an eosinophilic phenotype in combination with other medicines used to treat asthma. [7]
Ad
related to: asthma action plan 6 years later